Newsfeeds Archive - Page 2 of 5

1 minute read

News

Verona Pharma Expect To Submit New Drug Application To US FDA In Q2 Of 2023; To Release Additional Information From The Enhance Trials

March 7, 3:44 AM

“2023 is expected to be another pivotal year for Verona Pharma as we continue preparing for the planned commercial launch of ensifentrine in the US in 2024, if approved. We expect to submit a New Drug Application

VRNA

1 minute read

Verona Pharma Q4 EPS $(0.02) Beats $(0.10) Estimate, Sales $458.00K Miss $3.57M Estimate

By Benzinga Newsdesk

March 7, 3:41 AM

Verona Pharma (NASDAQ:VRNA) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.10) by 80 percent. This is a 95 percent increase over losses of $(0.40) per share from the same

VRNA

1 minute read

PDS Biotechnology, Pulmonx, Tesla And Some Other Big Stocks Moving Lower On Tuesday

By Lisa Levin

January 3, 12:01 PM

U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Tuesday. Here are some big stocks recording losses in today’s session.

ARQQ

1 minute read

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today

By Benzinga Insights

December 30, 11:03 AM

Verona Pharma (NASDAQ:VRNA) has outperformed the market over the past 5 years by 7.76% on an annualized basis…

VRNA

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

December 21, 1:32 PM

Gainers Venus Concept (NASDAQ:VERO) shares increased by 61.1% to $0.41 during Wednesday’s regular session. Trading volume for this…

BLPH

2 minute read

Tesla, Amazon, Nike, FedEx, Verona Pharma: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

December 20, 8:41 PM

Major Wall Street indices closed in the green on Tuesday, albeit just marginally higher, ending a four-day losing streak as investors and traders are watching out for a much anticipated year-end rally. Surprisingly, market partic

AMZN

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

December 20, 1:31 PM

Gainers Athenex (NASDAQ:ATNX) stock moved upwards by 41.4% to $0.19 during Tuesday’s regular session. Trading volume for this…

ATNX

1 minute read

BTIG Maintains Buy on Verona Pharma, Raises Price Target to $26

By Benzinga Newsdesk

December 20, 11:21 AM

BTIG analyst Thomas Shrader maintains Verona Pharma (NASDAQ:VRNA) with a Buy and raises the price target from $17 to $26.

VRNA

1 minute read

Verona Pharma Stock Garners Investors’ Attention After Successful COPD Trial

By Vandana Singh

December 20, 9:43 AM

Verona Pharma plc (NASDAQ:VRNA) has announced positive results of its Phase 3 ENHANCE-1 trial of nebulized ensifentrine for the maintenance treatment…

VRNA

3 minute read

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket

By Lisa Levin

December 20, 7:13 AM

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.

ADXN